tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Pasithea Therapeutics Corp

KTTA
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.397USD
-0.003-0.75%
์ข…๊ฐ€ย 10-27 16:00๏ผˆET๏ผ‰
13.26M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Pasithea Therapeutics Corp

0.397
-0.003-0.75%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

KTTA ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Pasithea Therapeutics Corp์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
13.26M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-0.28
์ฃผ๋‹น์ˆœ์ด์ต
-1.41
์ˆ˜์ต
--
์ˆœ์ด์ต
-13.90M
ROE
-58.22%
ROA
-55.58%
Pasithea Therapeutics Corp ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Aug 14, 2026
EPS / ์˜ˆ์ƒ
--/-0.16
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
75.06%-0.16
92.68%-0.12
68.75%-0.79
85.80%-0.41
82.22%-0.66
56.49%-1.61
38.45%-2.53
17.15%-2.87
-28.65%-3.71
-36.48%-3.70
-11.54%-4.12
---3.47
---2.88
---2.71
---3.69
---7.22
----
----
----
----
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--13.58K
----
--15.06K
----
์ˆœ์ด์ต
-41.92%-5.27M
19.47%-2.87M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
37.05%-3.18M
16.96%-3.00M
-2.74%-3.87M
-9.13%-3.86M
1.36%-5.05M
21.23%-3.61M
-41.56%-3.76M
-124.72%-3.54M
-912.17%-5.12M
-200.51%-4.59M
-265.19%-2.66M
-186.43%-1.57M
--630.12K
---1.53M
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.35%
--0.63%
----
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--13.58K
----
--15.06K
----
์˜์—… ์ด์ต
-49.92%-5.71M
-32.51%-4.88M
-214.65%-10.26M
-3.51%-3.11M
3.40%-3.81M
8.92%-3.68M
36.69%-3.26M
20.71%-3.00M
-3.04%-3.95M
-25.78%-4.04M
-27.36%-5.15M
1.72%-3.79M
-24.30%-3.83M
-54.53%-3.21M
-106.66%-4.04M
-202.74%-3.86M
-323.12%-3.08M
-278.25%-2.08M
---1.96M
---1.27M
์ˆœ์ด์ต
-41.92%-5.27M
19.47%-2.87M
-218.19%-10.11M
-1.25%-3.04M
3.88%-3.72M
7.71%-3.56M
37.05%-3.18M
16.96%-3.00M
-2.74%-3.87M
-9.13%-3.86M
1.36%-5.05M
21.23%-3.61M
-41.56%-3.76M
-124.72%-3.54M
-912.17%-5.12M
-200.51%-4.59M
-265.19%-2.66M
-186.43%-1.57M
--630.12K
---1.53M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
458.60%48.24M
760.93%52.73M
666.24%56.46M
-43.46%5.53M
-0.07%8.64M
-53.57%6.12M
-55.86%7.37M
-52.92%9.78M
-69.17%8.64M
-57.60%13.19M
-51.02%16.69M
-53.29%20.77M
-42.33%28.04M
-38.93%31.11M
-36.07%34.08M
111.42%44.47M
5156.97%48.61M
4368.80%50.95M
--53.30M
--21.03M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
5.81%1.84M
-6.61%1.49M
344.15%4.97M
108.53%1.38M
24.53%1.74M
-35.35%1.59M
-57.48%1.12M
-67.69%660.40K
-37.42%1.39M
16.25%2.47M
40.29%2.63M
35.00%2.04M
134.61%2.23M
389.33%2.12M
319.79%1.88M
186.69%1.51M
108.96%950.11K
81.11%433.68K
--447.28K
--528.10K
์ด ์ž์‚ฐ
204.01%51.71M
284.44%56.35M
274.98%60.24M
-26.86%13.63M
-3.70%17.01M
-34.58%14.66M
-38.49%16.06M
-39.21%18.64M
-53.70%17.66M
-46.70%22.41M
-42.19%26.12M
-38.20%30.66M
-28.06%38.15M
-17.69%42.04M
-15.27%45.18M
135.75%49.61M
5634.22%53.03M
4380.08%51.08M
--53.32M
--21.04M
๋ถ€์ฑ„ ์ด๊ณ„
2.16%1.87M
-8.20%1.54M
291.63%5.02M
72.82%1.42M
23.02%1.83M
-33.45%1.68M
-52.84%1.28M
-63.92%823.98K
-41.85%1.49M
-13.24%2.52M
1.36%2.72M
-19.00%2.28M
64.67%2.56M
164.24%2.91M
41.14%2.68M
-38.27%2.82M
241.81%1.55M
359.88%1.10M
--1.90M
--4.57M
์ž๋ณธ ์ด๊ณ„
228.36%49.84M
322.32%54.81M
273.54%55.22M
-31.47%12.21M
-6.16%15.18M
-34.73%12.98M
-36.82%14.78M
-37.22%17.81M
-54.55%16.18M
-49.19%19.88M
-44.94%23.40M
-39.36%28.37M
-30.86%35.59M
-21.69%39.14M
-17.35%42.50M
184.00%46.79M
10850.00%51.47M
5448.90%49.98M
--51.42M
--16.48M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-21.68%-4.71M
44.27%-1.70M
-120.91%-5.40M
7.38%-2.89M
4.21%-3.87M
29.28%-3.06M
25.84%-2.44M
3.63%-3.12M
-31.15%-4.04M
-34.94%-4.32M
-3.42%-3.29M
14.90%-3.24M
-29.56%-3.08M
-26.70%-3.20M
-82.61%-3.19M
-593.72%-3.80M
-375.94%-2.38M
-561.91%-2.53M
---1.74M
---548.44K
์ˆœํˆฌ์ž
----
----
--11.00K
----
----
----
----
-100.00%0.00
-100.00%0.00
100.00%0.00
102.33%54.54K
-57.25%50.16K
-37.05%24.39K
52.67%-53.89K
-18007.96%-2.34M
1468.96%117.32K
--38.75K
---113.87K
---12.93K
---8.57K
์ˆœ์žฌ๋ฌดํ™œ๋™
-99.85%8.48K
-99.95%750.00
239682.21%56.42M
-102.56%-116.14K
--5.74M
--1.47M
---23.55K
217.65%4.54M
100.00%0.00
-100.00%0.00
100.00%0.00
---3.86M
---130.77K
--264.10K
-109.38%-3.21M
-100.00%0.00
--0.00
-100.00%0.00
--34.17M
--20.55M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Pasithea Therapeutics Corp์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 56.46M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 666.24์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Pasithea Therapeutics Corp์˜ ์ด์ž์‚ฐ์€ 60.24M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 274.98์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Pasithea Therapeutics Corp์˜ ์ด๋ถ€์ฑ„๋Š” 5.02M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 291.63์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Pasithea Therapeutics Corp์˜ ์ด์ž๋ณธ์€ 55.22M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 273.54์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Pasithea Therapeutics Corp์˜ ์ˆœ์˜์—…์†Œ๋“์€ -20.86M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -46.37์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Pasithea Therapeutics Corp์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 63.52M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1306.02์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -2.91์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 77.10์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -20.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -46.91์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -58.36์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 19.87์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -53.54์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 18.79์ž…๋‹ˆ๋‹ค.

Pasithea Therapeutics Corp์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Pasithea Therapeutics Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -20.86M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -46.37์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ